BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, June 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 5, 2009
View Archived Issues
Biocompatibles and AstraZeneca sign agreements for GLP-1 analogue
Read More
Cytokinetics retains rights to ispinesib and SB-743921
Read More
MediciNova issues proposal to acquire Avigen
Read More
Ligand completes acquisition of Pharmacopeia
Read More
Novartis and AlphaVax sign exclusive license agreement for CMV vaccines
Read More
Daiichi Sankyo enters vaccine alliance with The Kitasato Institute
Read More
LifeCycle commences LCP-Tacro phase III trials
Read More
BI-2536 active and well tolerated in elderly patients with relapsed/refractory AML
Read More
Nabi reaches agreement with FDA on SPA for a phase III clinical trial of NicVax
Read More
Sosei reacquires commercialization rights to opioid analgesic AD-923 from Mundipharma
Read More
Salix receives FDA complete response letter for balsalazide
Read More
Savient's pegloticase BLA for treatment-failure gout granted priority review
Read More
FDA issues complete response letter to Ipsen for Dysport BLA in cervical dystonia
Read More
Clinical benefit seen with INCB-018424 in myelofibrosis
Read More
Results reported for phase II study of SGN-40 in diffuse large B-cell lymphoma
Read More
Breast cancer progression may be inhibited by fluvastatin
Read More
King acquires Alpharma
Read More
FDA accepts for filing Northfield Laboratories' BLA for PolyHeme
Read More
GTx submits NDA for toremifene for bone fracture prevention in prostate cancer
Read More
Johnson & Johnson plans short-form merger of Omrix
Read More
Urigen amends licence agreement with UCSD for URG-101
Read More
Novel matrix metalloproteinase inhibitors from Array BioPharma
Read More
New chymase inhibitors for cardiovascular diseases patented at Boehringer Ingelheim
Read More
New mgluR2 ligands/5-HT2A antagonists described in Abbott patent
Read More
SARS DNA vaccine safe, immunogenic in phase I study
Read More
